Author： Sharpe Norman
Publisher： Springer Publishing Company
ISSN： 0920-3206
Source： Cardiovascular Drugs and Therapy, Vol.19, Iss.3, 2005-05, pp. : 197-201
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Low-dose HRT: favourable results in the HOPE Study
Inpharma, Vol. 1, Iss. 1299, 2001-01 ,pp. :
Access to resources
Recommend
Cediranib: glimmer of hope in glioblastoma
Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. :
New hope for neglected diseases
Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. :
Inpharma, Vol. 1, Iss. 1338, 2002-01 ,pp. :
Recurrent hope for the treatment of preterm delivery
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. :